This Article Full Text Full Text (PDF) Supplementary Data All Versions of this Article: 0008-5472.CAN-08-2331v1 69/4/1284    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schnidar, H. Articles by Aberger, F. Search for Related Content PubMed PubMed Citation Articles by Schnidar, H. Articles by Aberger, F.

Epidermal Growth Factor Receptor Signaling Synergizes with Hedgehog/GLI in Oncogenic Transformation via Activation of the MEK/ERK/JUN Pathway

¹ Department of Molecular Biology, University of Salzburg; ² Department of Pathology, St. Johann's Hospital, Paracelsus Medical School, Salzburg, Austria; ³ Institute of Cancer Research, Medical University Vienna; and ⁴ Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria

Requests for reprints: Fritz Aberger, University of Salzburg, Hellbrunnerstrasse 34, Salzburg A-5020, Austria. Phone: 43-0-662-8044-5792; Fax: 43-0-662-8044-183; E-mail: fritz.aberger{at}sbg.ac.at.

Key Words: Hedgehog signaling • GLI transcription factors • epidermal growth factor receptor • activator protein-1 • basal cell carcinoma

Persistent activation of the Hedgehog (HH)/GLI signaling pathway has been implicated in the development of a number of human cancers. The GLI zinc finger transcription factors act at the end of the HH signaling cascade to control gene expression, and recent studies have shown that the activity of GLI proteins can be additionally modified by integration of distinct signals, such as the MEK/extracellular signal-regulated kinase (ERK) and phosphinositide-3 kinase (PI3K)/AKT pathway. However, little is known about the identity of the upstream activators of these HH/GLI interacting signaling pathways in cancer. Here, we provide evidence that integration of the HH/GLI and epidermal growth factor receptor (EGFR) pathway synergistically induces oncogenic transformation, which depends on EGFR-mediated activation of the RAS/RAF/MEK/ERK but not of the PI3K/AKT pathway. EGFR/MEK/ERK signaling induces JUN/activator protein 1 activation, which is essential for oncogenic transformation, in combination with the GLI activator forms GLI1 and GLI2. Furthermore, pharmacologic inhibition of EGFR and HH/GLI efficiently reduces growth of basal cell carcinoma (BCC) cell lines derived from mice with activated HH/GLI signaling. The results identify the synergistic integration of GLI activator function and EGFR signaling as a critical step in oncogenic transformation and provide a molecular basis for therapeutic opportunities relying on combined inhibition of the HH/GLI and EGFR/MEK/ERK/JUN pathway in BCC. [Cancer Res 2009;69(4):1284–92]

This article has been cited by other articles:

				H.-W. Lo, H. Zhu, X. Cao, A. Aldrich, and F. Ali-Osman A Novel Splice Variant of GLI1 That Promotes Glioblastoma Cell Migration and Invasion Cancer Res., September 1, 2009; 69(17): 6790 - 6798. [Abstract] [Full Text] [PDF]